| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Mar 2023 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.39B | 11.05B | 11.07B | 12.22B | 11.98B | 12.35B |
| Gross Profit | 3.42B | 3.10B | 2.38B | 3.39B | 3.10B | 3.83B |
| EBITDA | 4.13B | 4.77B | 4.58B | 4.79B | 4.76B | 5.52B |
| Net Income | 1.46B | 1.27B | 1.14B | 1.34B | 1.32B | 1.92B |
Balance Sheet | ||||||
| Total Assets | 57.42B | 57.60B | 59.79B | 56.35B | 57.61B | 57.81B |
| Cash, Cash Equivalents and Short-Term Investments | 6.83B | 6.70B | 5.28B | 5.23B | 5.09B | 4.68B |
| Total Debt | 9.11B | 10.22B | 10.07B | 8.53B | 12.81B | 9.30B |
| Total Liabilities | 12.96B | 13.00B | 16.38B | 13.62B | 15.87B | 16.76B |
| Stockholders Equity | 40.72B | 40.36B | 39.80B | 39.60B | 38.65B | 37.95B |
Cash Flow | ||||||
| Free Cash Flow | 4.88B | 5.23B | 3.65B | 2.67B | -21.57M | -1.43M |
| Operating Cash Flow | 5.39B | 5.71B | 4.29B | 3.34B | 3.41B | 3.82B |
| Investing Cash Flow | -472.03M | -543.41M | -221.38M | -349.15M | -3.10B | -2.69B |
| Financing Cash Flow | -3.97B | -3.79B | -4.02B | -3.03B | 286.46M | -3.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$63.40B | 7.14 | 11.51% | 5.34% | 1.02% | 0.36% | |
75 Outperform | HK$20.55B | 6.93 | 7.93% | 3.47% | 6.08% | 5.81% | |
73 Outperform | HK$38.70B | 9.45 | 3.62% | 3.23% | 8.66% | 53.27% | |
73 Outperform | HK$67.38B | 5.50 | 5.92% | 5.72% | 12.77% | -18.46% | |
69 Neutral | HK$4.43B | 3.20 | 4.48% | 6.69% | -14.81% | -3.39% | |
67 Neutral | HK$21.03B | 7.64 | 4.96% | 4.97% | 10.25% | -9.65% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |